ロード中...
Impact of High Deductible Insurance on Adjuvant Hormonal Therapy Use in Breast Cancer
OBJECTIVE: High-deductible health plans (HDHP) have become the predominant commercial health insurance arrangement in the United States. HDHPs require substantial out-of-pocket (OOP) costs for most services but often exempt medications from high cost sharing. We examined effects of HDHPs on OOP cost...
保存先:
| 出版年: | Breast Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6231999/ https://ncbi.nlm.nih.gov/pubmed/29754304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4821-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|